TP53 and pancreatic neoplasm: The KPflC mouse model, in which pancreatic cancer cells have lost p53 expression, has lower fibrosis (28) and rates of metastasis (37) compared to the KPC mouse model, which harbors a gain-of-function R172H mutation in p53.